169 related articles for article (PubMed ID: 24595047)
1. White matter signal abnormalities in children with suspected HIV-related neurologic disease on early combination antiretroviral therapy.
Ackermann C; Andronikou S; Laughton B; Kidd M; Dobbels E; Innes S; van Toorn R; Cotton M
Pediatr Infect Dis J; 2014 Aug; 33(8):e207-12. PubMed ID: 24595047
[TBL] [Abstract][Full Text] [Related]
2. HIV-associated CD4+/CD8+ depletion in infancy is associated with neurometabolic reductions in the basal ganglia at age 5 years despite early antiretroviral therapy.
Mbugua KK; Holmes MJ; Cotton MF; Ratai EM; Little F; Hess AT; Dobbels E; Van der Kouwe AJ; Laughton B; Meintjes EM
AIDS; 2016 Jun; 30(9):1353-62. PubMed ID: 26959509
[TBL] [Abstract][Full Text] [Related]
3. Neurodevelopmental/neuroradiologic recovery of a child infected with HIV after treatment with combination antiretroviral therapy using the HIV-specific protease inhibitor ritonavir.
Tepper VJ; Farley JJ; Rothman MI; Houck DL; Davis KF; Collins-Jones TL; Wachtel RC
Pediatrics; 1998 Mar; 101(3):E7. PubMed ID: 9493492
[TBL] [Abstract][Full Text] [Related]
4. Late-Onset Hiv Encephalopathy In Children With Long-Standing Virologic Suppression Followed By Slow Spontaneous Recovery Despite no Change In Antiretroviral Therapy: 4 Case Reports.
Innes S; van Toorn R; Otwombe K; Dobbels E; van Zyl G; Cotton MF; Laughton B
Pediatr Infect Dis J; 2017 Nov; 36(11):e264-e267. PubMed ID: 28719495
[TBL] [Abstract][Full Text] [Related]
5. White matter micro-structural changes in ART-naive and ART-treated children and adolescents infected with HIV in South Africa.
Hoare J; Fouche JP; Phillips N; Joska JA; Paul R; Donald KA; Thomas KG; Stein DJ
AIDS; 2015 Sep; 29(14):1793-801. PubMed ID: 26372385
[TBL] [Abstract][Full Text] [Related]
6. Neurodevelopmental delay among HIV-infected preschool children receiving antiretroviral therapy and healthy preschool children in Soweto, South Africa.
Lowick S; Sawry S; Meyers T
Psychol Health Med; 2012; 17(5):599-610. PubMed ID: 22313239
[TBL] [Abstract][Full Text] [Related]
7. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
[TBL] [Abstract][Full Text] [Related]
8. Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study.
le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Nguyen KK; Zerbe A; Kroon M; Myer L
Lancet Child Adolesc Health; 2019 Apr; 3(4):234-244. PubMed ID: 30773459
[TBL] [Abstract][Full Text] [Related]
9. Recovery of HIV encephalopathy in perinatally infected children on antiretroviral therapy.
Innes S; Laughton B; van Toorn R; Otwombe K; Liberty A; Dobbels E; Violari A; Kruger M; Cotton MF
Dev Med Child Neurol; 2020 Nov; 62(11):1309-1316. PubMed ID: 32779195
[TBL] [Abstract][Full Text] [Related]
10. Altered brain morphometry in 7-year old HIV-infected children on early ART.
Nwosu EC; Robertson FC; Holmes MJ; Cotton MF; Dobbels E; Little F; Laughton B; van der Kouwe A; Meintjes EM
Metab Brain Dis; 2018 Apr; 33(2):523-535. PubMed ID: 29209922
[TBL] [Abstract][Full Text] [Related]
11. Clinical factors related to brain structure in HIV: the CHARTER study.
Jernigan TL; Archibald SL; Fennema-Notestine C; Taylor MJ; Theilmann RJ; Julaton MD; Notestine RJ; Wolfson T; Letendre SL; Ellis RJ; Heaton RK; Gamst AC; Franklin DR; Clifford DB; Collier AC; Gelman BB; Marra C; McArthur JC; McCutchan JA; Morgello S; Simpson DM; Grant I;
J Neurovirol; 2011 Jun; 17(3):248-57. PubMed ID: 21544705
[TBL] [Abstract][Full Text] [Related]
12. Diffusion tensor imaging point to ongoing functional impairment in HIV-infected children at age 5, undetectable using standard neurodevelopmental assessments.
Ackermann C; Andronikou S; Saleh MG; Kidd M; Cotton MF; Meintjes EM; Laughton B
AIDS Res Ther; 2020 May; 17(1):20. PubMed ID: 32430069
[TBL] [Abstract][Full Text] [Related]
13. Antiretroviral drug therapy in HIV-infected Jamaican children.
Evans-Gilbert T; Pierre R; Steel-Duncan JC; Rodriguez B; Whorms S; Hambleton IR; Figueroa JP; Christie CD
West Indian Med J; 2004 Oct; 53(5):322-6. PubMed ID: 15675498
[TBL] [Abstract][Full Text] [Related]
14. Initiation of antiretroviral therapy before 6 months of age is associated with faster growth recovery in South African children perinatally infected with human immunodeficiency virus.
Shiau S; Arpadi S; Strehlau R; Martens L; Patel F; Coovadia A; Abrams EJ; Kuhn L
J Pediatr; 2013 Jun; 162(6):1138-45, 1145.e1-2. PubMed ID: 23312691
[TBL] [Abstract][Full Text] [Related]
15. Initiation of antiretroviral therapy after the critical neuronal developmental period of the second postnatal year affects white matter microstructure in adolescents living with HIV.
Hoare J; Heany SJ; Fouche JP; Phillips N; Joska JA; Myer L; Zar HJ; Stein DJ
J Neurovirol; 2019 Apr; 25(2):254-262. PubMed ID: 30617850
[TBL] [Abstract][Full Text] [Related]
16. Cognitive function and neurodevelopmental outcomes in HIV-infected Children older than 1 year of age randomized to early versus deferred antiretroviral therapy: the PREDICT neurodevelopmental study.
Puthanakit T; Ananworanich J; Vonthanak S; Kosalaraksa P; Hansudewechakul R; van der Lugt J; Kerr SJ; Kanjanavanit S; Ngampiyaskul C; Wongsawat J; Luesomboon W; Vibol U; Pruksakaew K; Suwarnlerk T; Apornpong T; Ratanadilok K; Paul R; Mofenson LM; Fox L; Valcour V; Brouwers P; Ruxrungtham K;
Pediatr Infect Dis J; 2013 May; 32(5):501-8. PubMed ID: 23263176
[TBL] [Abstract][Full Text] [Related]
17. Young age at start of antiretroviral therapy and negative HIV antibody results in HIV-infected children when suppressed.
Kuhn L; Schramm DB; Shiau S; Strehlau R; Pinillos F; Technau K; Coovadia A; Abrams EJ; Puren A; Tiemessen CT
AIDS; 2015 Jun; 29(9):1053-60. PubMed ID: 25870988
[TBL] [Abstract][Full Text] [Related]
18. Cognitive outcomes at ages seven and nine years in South African children from the children with HIV early antiretroviral (CHER) trial: a longitudinal investigation.
van Wyhe KS; Laughton B; Cotton MF; Meintjes EM; van der Kouwe AJ; Boivin MJ; Kidd M; Thomas KG
J Int AIDS Soc; 2021 Jul; 24(7):e25734. PubMed ID: 34259393
[TBL] [Abstract][Full Text] [Related]
19. Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort.
Robertson KR; Su Z; Margolis DM; Krambrink A; Havlir DV; Evans S; Skiest DJ;
Neurology; 2010 Apr; 74(16):1260-6. PubMed ID: 20237308
[TBL] [Abstract][Full Text] [Related]
20. Correlating brain volume and callosal thickness with clinical and laboratory indicators of disease severity in children with HIV-related brain disease.
Andronikou S; Ackermann C; Laughton B; Cotton M; Tomazos N; Spottiswoode B; Mauff K; Pettifor JM
Childs Nerv Syst; 2014 Sep; 30(9):1549-57. PubMed ID: 24853332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
